Hartmut Goldschmidt

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Seckinger A; Meissner T; Moreaux J; Goldschmidt H; Fuhler G M; Benner A; Hundemer M; Rème T; Shaughnessy J D; Barlogie B; Bertsch U; Hillengass J; Ho A D; Pantesco V; Jauch A; De Vos J; Rossi J F; Möhler T; Klein B; Hose D
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.
Rossi J-F; Moreaux J; Hose D; Requirand G; Rose M; Rouillé V; Nestorov I; Mordenti G; Goldschmidt H; Ythier A; Klein B
Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study.
Kristen Arnt V; Sack Falk-Udo; Schonland Stefan O; Hegenbart Ute; Helmke Burkhard M; Koch Achim; Schnabel Philipp A; Röcken Christoph; Hardt Stefan; Remppis Andrew; Goldschmidt Hartmut; Karck Matthias; Ho Anthony D; Katus Hugo A; Dengler Thomas J
Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hartmut Goldschmidt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Seckinger A; Meissner T; Moreaux J; Goldschmidt H; Fuhler G M; Benner A; Hundemer M; Rème T; Shaughnessy J D; Barlogie B; Bertsch U; Hillengass J; Ho A D; Pantesco V; Jauch A; De Vos J; Rossi J F; Möhler T; Klein B; Hose D
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.
Oncogene 2009;28(44):3866-79.
2009: Rossi J-F; Moreaux J; Hose D; Requirand G; Rose M; Rouillé V; Nestorov I; Mordenti G; Goldschmidt H; Ythier A; Klein B
Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study.
British journal of cancer 2009;101(7):1051-8.
2009: Kristen Arnt V; Sack Falk-Udo; Schonland Stefan O; Hegenbart Ute; Helmke Burkhard M; Koch Achim; Schnabel Philipp A; Röcken Christoph; Hardt Stefan; Remppis Andrew; Goldschmidt Hartmut; Karck Matthias; Ho Anthony D; Katus Hugo A; Dengler Thomas J
Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(10):1014-20.
2009: Goldschmidt H
[Autologous stem cell transplantation in multiple myeloma - pro]
Deutsche medizinische Wochenschrift (1946) 2009;134(39):1942.
2009: Bäuerle Tobias; Hillengass Jens; Fechtner Kerstin; Zechmann Christian M; Grenacher Lars; Moehler Thomas M; Christiane Heiss; Wagner-Gund Barbara; Neben Kai; Kauczor Hans-Ulrich; Goldschmidt Hartmut; Delorme Stefan
Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging.
Radiology 2009;252(2):477-85.
2009: Condomines Maud; Hose Dirk; Rème Thierry; Requirand Guilhem; Hundemer Michael; Schoenhals Matthieu; Goldschmidt Hartmut; Klein Bernard
Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(2):832-40.
2009: Christensen Olaf; Lupu Alaviana; Schmidt Stefanie; Condomines Maud; Belle Sebastian; Maier Ariane; Hose Dirk; Neuber Brigitte; Moos Marion; Kleist Christian; Terness Peter; Ho Anthony D; Goldschmidt Hartmut; Klein Bernard; Hundemer Michael
Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(6):613-21.
2009: Hose Dirk; Moreaux Jérôme; Meissner Tobias; Seckinger Anja; Goldschmidt Hartmut; Benner Axel; Mahtouk Karène; Hillengass Jens; Rème Thierry; De Vos John; Hundemer Michael; Condomines Maud; Bertsch Uta; Rossi Jean-François; Jauch Anna; Klein Bernard; Möhler Thomas
Induction of angiogenesis by normal and malignant plasma cells.
Blood 2009;114(1):128-43.
2009: Hillengass Jens; Zechmann Christian; Bäuerle Tobias; Wagner-Gund Barbara; Heiss Christiane; Benner Axel; Ho Anthony; Neben Kai; Hose Dirk; Kauczor Hans-Ulrich; Goldschmidt Hartmut; Delorme Stefan; Moehler Thomas
Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(9):3118-25.
2009: Bret Caroline; Hose Dirk; Reme Thierry; Sprynski Anne-Catherine; Mahtouk Karène; Schved Jean-François; Quittet Philippe; Rossi Jean-François; Goldschmidt Hartmut; Klein Bernard
Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells.
British journal of haematology 2009;145(3):350-68.
2009: Sprynski Anne Catherine; Hose Dirk; Caillot Laurent; Réme Thierry; Shaughnessy John D; Barlogie Bart; Seckinger Anja; Moreaux Jérôme; Hundemer Michael; Jourdan Michel; Meissner Tobias; Jauch Anna; Mahtouk Karène; Kassambara Alboukadel; Bertsch Uta; Rossi Jean François; Goldschmidt Hartmut; Klein Bernard
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor.
Blood 2009;113(19):4614-26.
2009: Jourdan Michel; Reme Thierry; Goldschmidt Hartmut; Fiol Geneviève; Pantesco Véronique; De Vos John; Rossi Jean-François; Hose Dirk; Klein Bernard
Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells.
British journal of haematology 2009;145(1):45-58.
2009: Hose Dirk; Rème Thierry; Meissner Tobias; Moreaux Jérôme; Seckinger Anja; Lewis Joe; Benes Vladimir; Benner Axel; Hundemer Michael; Hielscher Thomas; Shaughnessy John D; Barlogie Bart; Neben Kai; Krämer Alwin; Hillengass Jens; Bertsch Uta; Jauch Anna; De Vos John; Rossi Jean-François; Möhler Thomas; Blake Jonathon; Zimmermann Jürgen; Klein Bernard; Goldschmidt Hartmut
Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma.
Blood 2009;113(18):4331-40.
2009: Klein Ulrike; Kosely Florentina; Hillengass Jens; Hundemer Michael; Schmitt Stefan; Neben Kai; Moehler Thomas; Hegenbart Ute; Ho Anthony D; Goldschmidt Hartmut
Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone.
Annals of hematology 2009;88(1):67-71.
2008: Hillengass J; Ho A D; Goldschmidt H; Waldherr R; Moehler T M
Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis.
International journal of hematology 2008;88(4):454-6.
2008: Belle Sebastian; Han Fang; Condomines Maud; Christensen Olaf; Witzens-Harig Mathias; Kasper Bernd; Kleist Christian; Terness Peter; Moos Marion; Cremer Friedrich; Hose Dirk; Ho Anthony D; Goldschmidt Hartmut; Klein Bernard; Hundemer Michael
Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myeloma.
European journal of haematology 2008;81(1):26-35.
2008: Schonland Stefan O; Hansmann Jochen; Mechtersheimer Gunnhild; Goldschmidt Hartmut; Ho Anthony D; Hegenbart Ute
Bone involvement in patients with systemic AL amyloidosis mimics lytic myeloma bone disease.
Haematologica 2008;93(6):955-6.
2008: Hillengass Jens; Zechmann Christian M; Nadler Andreas; Hose Dirk; Cremer Friedrich W; Jauch Anna; Heiss Christiane; Benner Axel; Ho Anthony D; Bartram Claus R; Kauczor Hans-Ulrich; Delorme Stefan; Goldschmidt Hartmut; Moehler Thomas M
Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma.
International journal of cancer. Journal international du cancer 2008;122(12):2871-5.
2008: Bochtler Tilmann; Hegenbart Ute; Cremer Friedrich W; Heiss Christiane; Benner Axel; Hose Dirk; Moos Marion; Bila Jelena; Bartram Claus R; Ho Anthony D; Goldschmidt Hartmut; Jauch Anna; Schonland Stefan O
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability.
Blood 2008;111(9):4700-5.
2008: Frank Christian; Hundemer Michael; Ho Anthony D; Goldschmidt Hartmut; Witzens-Harig Mathias
Cellular immune responses against the cancer-testis antigen SPAN-XB in healthy donors and patients with multiple myeloma.
Leukemia & lymphoma 2008;49(4):779-85.
2008: Schmitt S; Mailaender V; Egerer G; Leo A; Becker S; Reinhardt P; Wiesneth M; Schrezenmeier H; Ho A D; Goldschmidt H; Moehler T M
Successful autologous peripheral blood stem cell transplantation in a Jehovah's Witness with multiple myeloma: review of literature and recommendations for high-dose chemotherapy without support of allogeneic blood products.
International journal of hematology 2008;87(3):289-97.
2008: Moehler Thomas M; Sauer Sandra; Witzel Maximilian; Andrulis Mindaugas; Garcia-Vallejo Juan J; Grobholz Rainer; Willhauck-Fleckenstein Martina; Greiner Axel; Goldschmidt Hartmut; Schwartz-Albiez Reinhard
Involvement of alpha 1-2-fucosyltransferase I (FUT1) and surface-expressed Lewis(y) (CD174) in first endothelial cell-cell contacts during angiogenesis.
Journal of cellular physiology 2008;215(1):27-36.
2008: Bochtler Tilmann; Hegenbart Ute; Heiss Christiane; Benner Axel; Cremer Friedrich; Volkmann Martin; Ludwig Jochen; Perz Jolanta B; Ho Anthony D; Goldschmidt Hartmut; Schonland Stefan O
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.
Haematologica 2008;93(3):459-62.
2008: Kristen Arnt V; Dengler Thomas J; Hegenbart Ute; Schonland Stefan O; Goldschmidt Hartmut; Sack Falk-Udo; Voss Frederik; Becker Rüdiger; Katus Hugo A; Bauer Alexander
Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.
Heart rhythm : the official journal of the Heart Rhythm Society 2008;5(2):235-40.
2008: Sack Falk-Udo; Kristen Arnt; Goldschmidt Hartmut; Schnabel Philipp A; Dengler Thomas; Koch Achim; Karck Matthias
Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2008;33(2):257-62.
2008: Lokhorst Henk M; Schmidt-Wolf Ingo; Sonneveld Pieter; van der Holt Bronno; Martin Hans; Barge Rene; Bertsch Uta; Schlenzka Jana; Bos Gerard M J; Croockewit Sandra; Zweegman Sonja; Breitkreutz Iris; Joosten Peter; Scheid Christof; van Marwijk-Kooy Marinus; Salwender Hans-Juergen; van Oers Marinus H J; Schaafsma Ron; Naumann Ralph; Sinnige Harm; Blau Igor; Delforge Michel; de Weerdt Okke; Wijermans Pierre; Wittebol Shulamiet; Duersen Ulrich; Vellenga Edo; Goldschmidt Hartmut;
Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.
Haematologica 2008;93(1):124-7.
2008: Rème Thierry; Hose Dirk; De Vos John; Vassal Aurélien; Poulain Pierre-Olivier; Pantesco Véronique; Goldschmidt Hartmut; Klein Bernard
A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments.
BMC bioinformatics 2008;9():16.
2007: Kristen Arnt V; Perz Jolanta B; Schonland Stefan O; Hansen Alexander; Hegenbart Ute; Sack Falk-Udo; Goldschmidt Hartmut; Katus Hugo A; Dengler Thomas J
Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2007;26(12):1313-9.
2007: Mahtouk Karène; Hose Dirk; De Vos John; Moreaux Jérôme; Jourdan Michel; Rossi Jean François; Rème Thierry; Goldschmidt Harmut; Klein Bernard
Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7289-95.
2007: Hundemer M; Klein U; Hose D; Raab M-S; Cremer F W; Jauch A; Benner A; Heiss C; Moos M; Ho A D; Goldschmidt H
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14).
Bone marrow transplantation 2007;40(11):1033-7.
2007: Witzens-Harig Mathias; Waldherr Rüdiger; Beimler Joerg; Zeier Martin; Hansmann Jochen; Ho Anthony D; Goldschmidt Hartmut; Moehler Thomas
Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
Annals of hematology 2007;86(12):927-30.
2007: Jourdan Michel; Moreaux Jérôme; Vos John De; Hose Dirk; Mahtouk Karène; Abouladze Matthieu; Robert Nicolas; Baudard Marion; Rème Thierry; Romanelli Angela; Goldschmidt Hartmut; Rossi Jean-François; Dreano Michel; Klein Bernard
Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth.
British journal of haematology 2007;138(2):160-8.
2007: Moreaux Jérôme; Hose Dirk; Jourdan Michel; Reme Thierry; Hundemer Michael; Moos Marion; Robert Nicolas; Moine Philippe; De Vos John; Goldschmidt Hartmut; Klein Bernard
TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines.
Haematologica 2007;92(6):803-11.
2007: Fruehauf S; Klaus J; Huesing J; Veldwijk M R; Buss E C; Topaly J; Seeger T; Zeller L W J; Moehler T; Ho A D; Goldschmidt H
Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma.
Bone marrow transplantation 2007;39(12):743-50.
2007: Breitkreutz I; Lokhorst H M; Raab M S; Holt B van der; Cremer F W; Herrmann D; Glasmacher A; Schmidt-Wolf I G H; Blau I W; Martin H; Salwender H; Haenel A; Sonneveld P; Goldschmidt H
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(6):1294-9.
2007: Kristen Arnt V; Perz Jolanta B; Schonland Stefan O; Hegenbart Ute; Schnabel Philipp A; Kristen Joern H; Goldschmidt Hartmut; Katus Hugo A; Dengler Thomas J
Non-invasive predictors of survival in cardiac amyloidosis.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(6-7):617-24.
2007: Mahtouk Karène; Hose Dirk; Raynaud Pierre; Hundemer Michael; Jourdan Michel; Jourdan Eric; Pantesco Veronique; Baudard Marion; De Vos John; Larroque Marion; Moehler Thomas; Rossi Jean-Francois; Rème Thierry; Goldschmidt Hartmut; Klein Bernard
Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma.
Blood 2007;109(11):4914-23.
2007: Condomines Maud; Hose Dirk; Raynaud Pierre; Hundemer Michael; De Vos John; Baudard Marion; Moehler Thomas; Pantesco Véronique; Moos Marion; Schved Jean-François; Rossi Jean-François; Rème Thierry; Goldschmidt Hartmut; Klein Bernard
Cancer/testis genes in multiple myeloma: expression patterns and prognosis value determined by microarray analysis.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(5):3307-15.
2007: Hillengass Jens; Wasser Klaus; Delorme Stefan; Kiessling Fabian; Zechmann Christian; Benner Axel; Kauczor Hans-Ulrich; Ho Anthony D; Goldschmidt Hartmut; Moehler Thomas M
Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(2 Pt 1):475-81.
2007: Klaus Jens; Herrmann Doris; Breitkreutz Iris; Hegenbart Ute; Mazitschek Uta; Egerer Gerlinde; Cremer Friedrich W; Lowenthal Ray M; Huesing Johannes; Fruehauf Stefan; Moehler Thomas; Ho Anthony D; Goldschmidt Hartmut
Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
European journal of haematology 2007;78(1):21-8.
2006: Moehler T M; Hillengass J; Glasmacher A; Goldschmidt H
Thalidomide in multiple myeloma.
Current pharmaceutical biotechnology 2006;7(6):431-40.
2006: Perz J B; Kristen A V; Rahemtulla A; Parameshwar J; Sack F-U; Apperley J F; Goldschmidt H; Katus H A; Dengler T J
Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation.
Clinical research in cardiology : official journal of the German Cardiac Society 2006;95(12):671-4.
2006: Moreaux Jerome; Hose Dirk; Reme Thierry; Jourdan Eric; Hundemer Michael; Legouffe Eric; Moine Philippe; Bourin Philippe; Moos Marion; Corre Jill; Möhler Thomas; De Vos John; Rossi Jean Francois; Goldschmidt Hartmut; Klein Bernard
CD200 is a new prognostic factor in multiple myeloma.
Blood 2006;108(13):4194-7.
2006: Raab Marc S; Breitkreutz Iris; Hundemer Michael; Benner Axel; Klaus Jens; Hegenbart Ute; Moehler Thomas; Ho Anthony D; Zeier Martin; Goldschmidt Hartmut
The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure.
Haematologica 2006;91(11):1555-8.
2006: Mahtouk K; Cremer F W; Rème T; Jourdan M; Baudard M; Moreaux J; Requirand G; Fiol G; De Vos J; Moos M; Quittet P; Goldschmidt H; Rossi J-F; Hose D; Klein B
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma.
Oncogene 2006;25(54):7180-91.
2006: Zahlten-Hinguranage A; Goldschmidt H; Cremer F W; Egerer G; Moehler T; Witte D; Bernd L; Sabo D; Zeifang F
Preoperative elevation of serum C--reactive protein is predictive for prognosis in myeloma bone disease after surgery.
British journal of cancer 2006;95(7):782-7.
2006: Li Guzi; Hundemer Michael; Wolfrum Sonja; Ho Anthony D; Goldschmidt Hartmut; Witzens-Harig Mathias
Identification and characterization of HLA-class-I-restricted T-cell epitopes in the putative tumor-associated antigens P21-activated serin kinase 2 (PAK2) and cyclin-dependent kinase inhibitor 1A (CDKN1A).
Annals of hematology 2006;85(9):583-90.
2006: Fruehauf Stefan; Seeger Timon; Maier Patrick; Li Li; Weinhardt Stephan; Laufs Stephanie; Wagner Wolfgang; Eckstein Volker; Bridger Gary; Calandra Gary; Wenz Frederick; Zeller W Jens; Goldschmidt Hartmut; Ho Anthony D
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics.
Experimental hematology 2006;34(8):1052-9.
2006: van de Donk N W C J; Kröger N; Hegenbart U; Corradini P; San Miguel J F; Goldschmidt H; Perez-Simon J A; Zijlmans M; Raymakers R A; Montefusco V; Ayuk F A; van Oers M H J; Nagler A; Verdonck L F; Lokhorst H M
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.
Bone marrow transplantation 2006;37(12):1135-41.
2006: Schmidt-Wolf I G H; Glasmacher A; Hahn-Ast C; Jüttner A; Schnurr T; Cremer F; Moehler T; Goldschmidt H; Busert B; Schubert R; Schwanitz G
Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance.
Cancer genetics and cytogenetics 2006;167(1):20-5.
2006: Hess Thomas; Egerer Gerlinde; Kasper Bernd; Rasul Kakil Ibrahim; Goldschmidt Hartmut; Kauffmann G W
Atypical manifestations of multiple myeloma: radiological appearance.
European journal of radiology 2006;58(2):280-5.
2006: De Vos John; Hose Dirk; Rème Thierry; Tarte Karin; Moreaux Jérôme; Mahtouk Karéne; Jourdan Michel; Goldschmidt Hartmut; Rossi Jean-François; Cremer Friedrich W; Klein Bernard
Microarray-based understanding of normal and malignant plasma cells.
Immunological reviews 2006;210():86-104.
2006: van de Donk Niels W C J; Kröger Nicolaus; Hegenbart Ute; Corradini Paolo; San Miguel Jesus F; Goldschmidt Hartmut; Perez-Simon Jose A; Zijlmans Mark; Raymakers Reinier A; Montefusco Vittorio; Ayuk Francis A; van Oers Marinus H J; Nagler Arnon; Verdonck Leo F; Lokhorst Henk M
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
Blood 2006;107(8):3415-6.
2006: Hundemer Michael; Schmidt Stefanie; Condomines Maud; Lupu Alaviana; Hose Dirk; Moos Marion; Cremer Friedrich; Kleist Christian; Terness Peter; Belle Sebastian; Ho Anthony D; Goldschmidt Hartmut; Klein Bernard; Christensen Olaf
Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.
Experimental hematology 2006;34(4):486-96.
2006: Glasmacher Axel; Hahn Corinna; Hoffmann Florian; Naumann Ralph; Goldschmidt Hartmut; von Lilienfeld-Toal Marie; Orlopp Katjana; Schmidt-Wolf Ingo; Gorschlüter Marcus
A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma.
British journal of haematology 2006;132(5):584-93.
2006: Schönland Stefan O; Lokhorst Henk; Buzyn Agnes; Leblond Veronique; Hegenbart Ute; Bandini Giuseppe; Campbell Andrew; Carreras Enric; Ferrant Augustin; Grommisch Leanthe; Jacobs Peter; Kröger Nicolaus; La Nasa Giorgio; Russell Nigel; Zachee Pierre; Goldschmidt Hartmut; Iacobelli Simona; Niederwieser Dietger; Gahrton Gösta;
Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation.
Blood 2006;107(6):2578-84.
2006: Harter C; Schulze B; Goldschmidt H; Benner A; Geiss H K; Hoppe-Tichy T; Ho A D; Egerer G
Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
Bone marrow transplantation 2006;37(4):373-9.
2005: Gerull S; Goerner M; Benner A; Hegenbart U; Klein U; Schaefer H; Goldschmidt H; Ho A D
Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma.
Bone marrow transplantation 2005;36(11):963-9.
2005: Ostendorf Torben; Meinhold Andrea; Harter Christoph; Salwender Hans; Egerer Gerlinde; Geiss Heinrich K; Ho Antony D; Goldschmidt Hartmut
Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2005;13(12):993-1000.
2005: Cremer Friedrich W; Bila Jelena; Buck Isabelle; Kartal Mutlu; Hose Dirk; Ittrich Carina; Benner Axel; Raab Marc S; Theil Ann-Cathrin; Moos Marion; Goldschmidt Hartmut; Bartram Claus R; Jauch Anna
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics.
Genes, chromosomes & cancer 2005;44(2):194-203.
2005: Schonland Stefan O; Perz Jolanta B; Hundemer Michael; Hegenbart Ute; Kristen Arnt V; Hund Ernst; Dengler Thomas J; Beimler Jorg; Zeier Martin; Singer Reinhard; Linke Reinhold P; Ho Anthony D; Goldschmidt Hartmut
Indications for high-dose chemotherapy with autologous stem cell support in patients with systemic amyloid light chain amyloidosis.
Transplantation 2005;80(1 Suppl):S160-3.
2005: Singer Reinhard; Mehrabi Arianeb; Schemmer Peter; Kashfi Arash; Hegenbart Ute; Goldschmidt Hartmut; Schönland Stefan; Kristen Arnt; Dengler Thomas; Müller-Schilling Martina; Sauer Peter; Dogan Ayhan; Hund Ernst; Helmke Burkhard; Schnabel Philipp; Altland Klaus; Linke Reinhold; Friess Helmut; Schmidt Jan; Büchler Markus W; Kraus Thomas W
Indications for liver transplantation in patients with amyloidosis: a single-center experience with 11 cases.
Transplantation 2005;80(1 Suppl):S156-9.
2005: Kristen Arnt V; Meyer F Joachim; Perz Jolanta B; Schonland Stefan O; Hundemer Michael; Hegenbart Ute; Singer Reinhard; Schnabel Philipp A; Sack Falk-Udo; Goldschmidt Hartmut; Katus Hugo A; Dengler Thomas J
Risk stratification in cardiac amyloidosis: novel approaches.
Transplantation 2005;80(1 Suppl):S151-5.
2005: Cremer Friedrich W; Kartal Mutlu; Hose Dirk; Bila Jelena; Buck Isabelle; Bellos Frauke; Raab Marc-Steffen; Brough Michaela; Moebus Anke; Hager Hans-Dieter; Goldschmidt Hartmut; Moos Marion; Bartram Claus R; Jauch Anna
High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH.
Cancer genetics and cytogenetics 2005;161(2):116-24.
2005: Wasser K; Moehler T; Nosas-Garcia S; Rehm C; Bartl R; Goldschmidt H; Düber C; Kauczor H U; Delorme S
[Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2005;177(8):1116-22.
2005: Moreaux Jérôme; Cremer Friedrich W; Reme Thierry; Raab Marc; Mahtouk Karene; Kaukel Philine; Pantesco Veronique; De Vos John; Jourdan Eric; Jauch Anna; Legouffe Eric; Moos Marion; Fiol Genevieve; Goldschmidt Hartmut; Rossi Jean François; Hose Dirk; Klein Bernard
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature.
Blood 2005;106(3):1021-30.
2005: Lotz Carina; Mutallib Sarah Abdel; Oehlrich Nicole; Liewer Ulrike; Ferreira Edite Antunes; Moos Marion; Hundemer Michael; Schneider Sandra; Strand Susanne; Huber Christoph; Goldschmidt Hartmut; Theobald Matthias
Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(2):1301-9.
2005: Nosàs-Garcia Sílvia; Moehler Thomas; Wasser Klaus; Kiessling Fabian; Bartl Reiner; Zuna Ivan; Hillengass Jens; Goldschmidt Hartmut; Kauczor Hans-Ulrich; Delorme Stefan
Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markers.
Journal of magnetic resonance imaging : JMRI 2005;22(1):154-62.
2005: Mahtouk Karène; Hose Dirk; Rème Thierry; De Vos John; Jourdan Michel; Moreaux Jérôme; Fiol Geneviève; Raab Marc; Jourdan Eric; Grau Véronique; Moos Marion; Goldschmidt Hartmut; Baudard Marion; Rossi Jean François; Cremer Friedrich W; Klein Bernard
Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells.
Oncogene 2005;24(21):3512-24.
2005: Raab M S; Cremer F W; Breitkreutz I N; Gerull S; Luft T; Benner A; Goerner M; Ho A D; Goldschmidt H; Moos M
Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(4):611-7.
2005: Choi Carmen; Witzens Mathias; Bucur Marianna; Feuerer Markus; Sommerfeldt Nora; Trojan Andreas; Ho Anthony; Schirrmacher Volker; Goldschmidt Hartmut; Beckhove Philipp
Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma.
Blood 2005;105(5):2132-4.
2005: Zeifang F; Zahlten-Hinguranage A; Goldschmidt H; Cremer F; Bernd L; Sabo D
Long-term survival after surgical intervention for bone disease in multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):222-7.
2004: Perz Jolanta B; Schonland Stefan O; Hundemer Michael; Kristen Arnt V; Dengler Thomas J; Zeier Martin; Linke Reinhold P; Ho Anthony D; Goldschmidt Hartmut
High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
British journal of haematology 2004;127(5):543-51.
2004: Minnema M C; Breitkreutz I; Auwerda J J A; van der Holt B; Cremer F W; van Marion A M W; Westveer P H M; Sonneveld P; Goldschmidt H; Lokhorst H M
Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(12):2044-6.
2004: Schlenzka Jana; Moehler Thomas M; Kipriyanov Sergey M; Kornacker Martin; Benner Axel; Bähre Alexandra; Stassar Marike J J G; Schäfer Holger J; Little Melvyn; Goldschmidt Hartmut; Cochlovius Björn
Combined effect of recombinant CD19 x CD16 diabody and thalidomide in a preclinical model of human B cell lymphoma.
Anti-cancer drugs 2004;15(9):915-9.
2004: Wasser K; Moehler T; Neben K; Nosas S; Heiss J; Goldschmidt H; Hillengass J; Düber C; Kauczor H U; Delorme S
[Dynamic MRI of the bone marrow for monitoring multiple myeloma during treatment with thalidomide as monotherapy or in combination with CED chemotherapy]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2004;176(9):1285-95.
2004: Kasper B; Lehnert T; Bernd L; Mechtersheimer G; Goldschmidt H; Ho A D; Egerer G
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas.
Bone marrow transplantation 2004;34(1):37-41.
2004: Witzens Mathias; Moehler Thomas; Neben Kai; Fruehauf Stefan; Hartschuh Wolfgang; Ho Anthony D; Goldschmidt Hartmut
Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide.
Annals of hematology 2004;83(7):467-70.
2004: Morath Christian; Mueller Martina; Goldschmidt Hartmut; Schwenger Vedat; Opelz Gerhard; Zeier Martin
Malignancy in renal transplantation.
Journal of the American Society of Nephrology : JASN 2004;15(6):1582-8.
2004: Hug Andreas; Storch-Hagenlocher Brigitte; Haas Juergen; Vogt-Schaden Maria-Elisabeth; Goldschmidt Hartmut; Wildemann Brigitte
Single-cell PCR analysis of the immunoglobulin heavy-chain CDR3 region for the diagnosis of leptomeningeal involvement of B-cell malignancies using standard cerebrospinal fluid cytospins.
Journal of the neurological sciences 2004;219(1-2):83-8.
2004: Moehler T M; Hillengass J; Goldschmidt H; Ho A D
Antiangiogenic therapy in hematologic malignancies.
Current pharmaceutical design 2004;10(11):1221-34.
2003: Goldschmidt Hartmut; Egerer Gerlinde; Fruehauf Stefan; Ho Anthony D
[Stem cells in hematology and oncology]
Medizinische Klinik (Munich, Germany : 1983) 2003;98 Suppl 2():11-4.
2003: Zeier Martin; Perz Jolanta; Linke Reinhold P; Donini Ugo; Waldherr Rüdiger; Andrassy Konrad; Ho Anthony D; Goldschmidt Hartmut
No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(12):2644-7.
2003: Harter C; Ostendorf T; Bach A; Egerer G; Goldschmidt H; Ho A D
Peripherally inserted central venous catheters for autologous blood progenitor cell transplantation in patients with haematological malignancies.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(12):790-4.
2003: Luft Thomas; Moos Marion; Goldschmidt Hartmut; Ho Anthony D; Görner Martin
Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myeloma.
British journal of haematology 2003;123(4):646-53.
2003: Goldschmidt H; Sonneveld P; Cremer F W; van der Holt B; Westveer P; Breitkreutz I; Benner A; Glasmacher A; Schmidt-Wolf I G D; Martin H; Hoelzer D; Ho A D; Lokhorst H M;
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients.
Annals of hematology 2003;82(10):654-9.
2003: Streitberger Konrad; Friedrich-Rust Mireen; Bardenheuer Hubert; Unnebrink Kristina; Windeler Jürgen; Goldschmidt Hartmut; Egerer Gerlinde
Effect of acupuncture compared with placebo-acupuncture at P6 as additional antiemetic prophylaxis in high-dose chemotherapy and autologous peripheral blood stem cell transplantation: a randomized controlled single-blind trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2538-44.
2003: Egerer G; Harter C; Karthaus M; Ho A D; Goldschmidt H
Use of erythropoietin in patients with multiple myeloma.
Onkologie 2003;26(1):80-4.
2003: Egerer Gerlinde; Goldschmidt Hartmut; Zoz Martin; Ho Anthony D
Autologous bone marrow transplantation in adult patients with acute lymphoblastic leukemia.
Leukemia & lymphoma 2003;44(1):9-14.
2003: Seggewiss Ruth; Buss Eike Christian; Herrmann Doris; Goldschmidt Hartmut; Ho Anthony Dick; Fruehauf Stefan
Kinetics of peripheral blood stem cell mobilization following G-CSF-supported chemotherapy.
Stem cells (Dayton, Ohio) 2003;21(5):568-74.
2002: Neben Kai; Moehler Thomas; Benner Axel; Kraemer Alwin; Egerer Gerlinde; Ho Anthony D; Goldschmidt Hartmut
Dose-dependent effect of thalidomide on overall survival in relapsed multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3377-82.
2002: Egerer G; Goldschmidt H; Hensel M; Harter C; Schneeweiss A; Ehrhard I; Bastert G; Ho A D
Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation.
Bone marrow transplantation 2002;30(7):427-31.
2002: Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho A D; Goldschmidt H; Hehlmann R
Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1844-51.
2002: Neben Kai; Mytilineos Joannis; Moehler Thomas M; Preiss Astrid; Kraemer Alwin; Ho Anthony D; Opelz Gerhard; Goldschmidt Hartmut
Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma.
Blood 2002;100(6):2263-5.
2002: Görner M; Kordelas L; Thalheimer M; Luft T; Pfeiffer S; Ustaoglu F; Punzel M; Weber-Nordt R; Moos M; Goldschmidt H; Ho A D
Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine.
Bone marrow transplantation 2002;29(7):621-4.
2002: Gemmel C; Cremer F W; Weis M; Witzens M; Moldenhauer G; Koniczek K-H; Imbach U; Ho A D; Moos M; Goldschmidt H
Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation.
Annals of hematology 2002;81(2):119-23.
2002: Hensel M; Egerer G; Schneeweiss A; Goldschmidt H; Ho A D
Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(2):209-17.
2002: Harter Christoph; Salwender Hans Jürgen; Bach Alfons; Egerer Gerlinde; Goldschmidt Hartmut; Ho Anthony D
Catheter-related infection and thrombosis of the internal jugular vein in hematologic-oncologic patients undergoing chemotherapy: a prospective comparison of silver-coated and uncoated catheters.
Cancer 2002;94(1):245-51.
2001: Moehler T M; Neben K; Ho A D; Goldschmidt H
Angiogenesis in hematologic malignancies.
Annals of hematology 2001;80(12):695-705.
2001: Moehler T M; Neben K; Benner A; Egerer G; Krasniqi F; Ho A D; Goldschmidt H
Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy.
Blood 2001;98(13):3846-8.
2001: Neben K; Moehler T; Kraemer A; Benner A; Egerer G; Ho A D; Goldschmidt H
Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion.
British journal of haematology 2001;115(3):605-8.
2001: Lipinski E; Cremer F W; Ho A D; Goldschmidt H; Moos M
Molecular monitoring of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 2001;28(10):957-62.
2001: Neben K; Moehler T; Egerer G; Kraemer A; Hillengass J; Benner A; Ho A D; Goldschmidt H
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(9):2675-81.
2001: Moehler T M; Hawighorst H; Neben K; Egerer G; Hillengass J; Max R; Benner A; Ho A D; van Kaick G; Goldschmidt H
Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging.
International journal of cancer. Journal international du cancer 2001;93(6):862-8.
2001: Egerer G; Hegenbart U; Salwender H; Haas R; Hahn U; Schmier J W; Ho A D; Goldschmidt H
Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2001;9(5):380-5.
2001: Egerer G; Goldschmidt H; Müller I; Karthaus M; Günther H; Ho A D
Ceftriaxone for the treatment of febrile episodes in nonneutropenic patients with hematooncological disease or HIV infection: comparison of outpatient and inpatient care.
Chemotherapy 2001;47(3):219-25.
2001: Abdallah A; Egerer G; Goldschmidt H; Wannenmacher M; Körbling M; Ho A D
Continuous complete remission in adult patients with acute lymphocytic leukaemia at a median observation of 12 years after autologous bone marrow transplantation.
British journal of haematology 2001;112(4):1012-5.
2001: Egerer G; Witzens M; Spaeth A; Breitbart A; Möller P; Goldschmidt H; Ho A D
Successful treatment of bronchiolitis obliterans organizing pneumonia with low-dose methotrexate in a patient with Hodgkin's disease.
Oncology 2001;61(1):23-7.
2000: Neben K; Hohaus S; Goldschmidt H; Egerer G; Voso M T; Ho A D; Haas R
High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors.
Annals of hematology 2000;79(10):547-55.
2000: Cremer F W; Ehrbrecht E; Kiel K; Benner A; Hegenbart U; Ho A D; Goldschmidt H; Moos M
Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myeloma.
Bone marrow transplantation 2000;26(8):851-8.
2000: Waldmann V; Goldschmidt H; Jäckel A; Deichmann M; Hegenbart U; Hartschuh W; Ho A; Näher H
Transient complete remission of metastasized Merkel cell carcinoma by high-dose polychemotherapy and autologous peripheral blood stem cell transplantation.
The British journal of dermatology 2000;143(4):837-9.
2000: Moehler T M; Hawighorst H; Neben K; Egerer G; Benner A; Hillengass J; Max R; Ho A D; Goldschmidt H; van Kaick G
[Functional magnetic resonance tomography in the diagnosis and therapy monitoring in multiple myeloma]
Der Radiologe 2000;40(8):723-30.
2000: Bösing T; Bellos F; Cremer F W; Gemmel C; Moldenhauer G; Ho A D; Goldschmidt H; Moos M
CD19+ and CD20+ B cells from the peripheral blood of patients with multiple myeloma are not infected with human herpesvirus 8.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(7):1330-1.
2000: Egerer G; Goldschmidt H; Salwender H; Hegenbart U; Ehrhard I; Haas R; Ho A D
Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation.
International journal of antimicrobial agents 2000;15(2):119-23.
2000: Goldschmidt H; Egerer G; Ho A D
Autologous and allogeneic stem cell transplantation in multiple myeloma.
Bone marrow transplantation 2000;25 Suppl 2():S25-6.
2000: Cremer F W; Goldschmidt H
Multiple myeloma--current concepts for an interdisciplinary management. A one-day course in the continuing education program organized by the Tumor Center Heidelberg/Mannheim. 24 April 1999, Heidelberg, Germany.
Journal of cancer research and clinical oncology 2000;126(3):181-4.
2000: Egerer G; Hegenbart U; Salwender H J; Goldschmidt H; Ho A D
Treatment of chemotherapy-induced emesis.
Antibiotics and chemotherapy 2000;50():171-83.
2000: Salwender H J; Egerer G; Bach A; Hahn U; Goldschmidt H; Ho A D
Central venous catheter-related complications.
Antibiotics and chemotherapy 2000;50():133-43.
2000: Stilgenbauer F; Egerer G; Karthaus M; Goldschmidt H; Ho A D
Recombinant human erythropoietin in the treatment of cancer.
Antibiotics and chemotherapy 2000;50():106-14.
2000: Egerer G; Karthaus M; Goldschmidt H; Ho A D
Antimicrobial therapy in neutropenic patients.
Antibiotics and chemotherapy 2000;50():20-5.
1999: Mantaka P; Strauss A D; Strauss L G; Moehler M; Goldschmidt H; Oberdorfer F; Kontaxakis G; Van Kaick G
Detection of treated liver metastases using fluorine-18-fluordeoxyglucose (FDG) and positron emission tomography (PET).
Anticancer research 1999;19(5C):4443-50.
1999: Egerer G; Goldschmidt H; Streich N; Ehrhard I; Sonntag H G; Haas R
Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1999;7(5):336-42.
1999: Rottenburger C; Kiel K; Bösing T; Cremer F W; Moldenhauer G; Ho A D; Goldschmidt H; Moos M
Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation.
British journal of haematology 1999;106(2):545-52.
1999: Kiel K; Cremer F W; Rottenburger C; Kallmeyer C; Ehrbrecht E; Atzberger A; Hegenbart U; Goldschmidt H; Moos M
Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation.
Bone marrow transplantation 1999;23(10):1019-27.
1999: Bellos F; Goldschmidt H; Dörner M; Ho A D; Moos M
Bone marrow derived dendritic cells from patients with multiple myeloma cultured with three distinct protocols do not bear Kaposi's sarcoma associated herpesvirus DNA.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(3):323-7.
1999: Hohaus S; Funk L; Martin S; Schlenk R F; Abdallah A; Hahn U; Egerer G; Goldschmidt H; Schneeweiss A; Fersis N; Kaul S; Wallwiener D; Bastert G; Haas R
Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer.
British journal of cancer 1999;79(9-10):1500-7.
1999: Voso M T; Hohaus S; Moos M; Pförsich M; Cremer F W; Schlenk R F; Martin S; Hegenbart U; Goldschmidt H; Haas R
Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content.
British journal of haematology 1999;104(2):382-91.
1998: Bellos F; Cremer F W; Ehrbrecht E; Goldschmidt H; Moos M
Leukapheresis cells of patients with multiple myeloma collected after mobilization with chemotherapy and G-CSF do not bear Kaposi's sarcoma associated herpesvirus DNA.
British journal of haematology 1998;103(4):1192-7.
1998: Witzens M; Egerer G; Stahl D; Werle E; Goldschmidt H; Haas R
A case of mu heavy-chain disease associated with hyperglobulinemia, anemia, and a positive Coombs test.
Annals of hematology 1998;77(5):231-4.
1998: Hohaus S; Martin H; Wassmann B; Egerer G; Haus U; Färber L; Burger K J; Goldschmidt H; Hoelzer D; Haas R
Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
Bone marrow transplantation 1998;22(7):625-30.
1998: Cremer F W; Kiel K; Wallmeier M; Haas R; Goldschmidt H; Moos M
Leukapheresis products in multiple myeloma: lower tumor load after mobilization with cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) compared with G-CSF alone.
Experimental hematology 1998;26(10):969-75.
1998: Kiel K; Cremer F W; Ehrbrecht E; Wallmeier M; Hegenbart U; Goldschmidt H; Moos M
First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yield.
Bone marrow transplantation 1998;21(11):1109-15.
1998: Martin-Murea S; Voso M T; Hohaus S; Pförsich M; Fruehauf S; Goldschmidt H; Hegenbart U; Haas R
The dose of granulocyte colony-stimulating factor administered following cytotoxic chemotherapy is not related to the rebound level of circulating CD34+ haemopoietic progenitor cells during marrow recovery.
British journal of haematology 1998;101(3):582-5.
1998: Kallmeyer C; Wallmeier M; Kiel K; Moos M; Hegenbart U; Haas R; Goldschmidt H
Decreased numbers of circulating B cells in myeloma patients with reduction after conventional chemotherapy.
American journal of hematology 1998;57(4):287-92.
1998: Goldschmidt H; Salwender H J; Hahn U; Hegenbart U; Egerer G; Wallmeier M; Jansen B; Haas R
Increased risk of catheter colonization and catheter-related infections in severe immunocompromized patients with multiple myeloma undergoing high-dose glucocorticoid treatment.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1998;287(1-2):125-34.
1998: Huober J; Schneeweiss A; Hohaus S; Wittmann G; Meyer A; Martin S; Goldschmidt H; Bastert G; Haas R; Wallwiener D
Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer.
Journal of cancer research and clinical oncology 1998;124(12):690-4.
1998: Goldschmidt H; Hegenbart U; Wallmeier M; Hohaus S; Engenhart R; Wannenmacher M; Haas R
Peripheral blood progenitor cell transplantation in multiple myeloma following high-dose melphalan-based therapy.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;144():27-35.
1997: Cremer F W; Kiel K; Sucker C; Wacker J; Atzberger A; Haas R; Goldschmidt H; Moos M
A rationale for positive selection of peripheral blood stem cells in multiple myeloma: highly purified CD34+ cell fractions of leukapheresis products do not contain malignant cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11 Suppl 5():S41-6.
1997: Goldschmidt H; Hegenbart U; Wallmeier M; Moos M; Haas R
High-dose chemotherapy in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11 Suppl 5():S27-31.
1997: Goldschmidt H; Hegenbart U; Wallmeier M; Hohaus S; Haas R
Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma.
British journal of haematology 1997;98(3):736-44.
1997: Cremer F W; Kiel K; Wallmeier M; Goldschmidt H; Moos M
A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(7):633-6.
1997: Goldschmidt H; Salwender H; Egerer G; Kempe R; Voigt T
Comparison of oral itasetron with oral ondansetron: results of a double-blind, active-controlled phase II study in chemotherapy-naive patients receiving moderately emetogenic chemotherapy.
Anti-cancer drugs 1997;8(5):436-44.
1997: Egerer G; Hegenbart U; Salwender H; Hahn U; Haas R; Goldschmidt H; Hunstein W
[Ambulatory therapy of multiple myeloma with vincristine, adriamycin and dexamethasone]
Deutsche medizinische Wochenschrift (1946) 1997;122(17):531-5.
1997: Haas R; Schmid H; Hahn U; Hohaus S; Goldschmidt H; Murea S; Kaufmann M; Wannenmacher M; Wallwiener D; Bastert G; Hunstein W
Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer.
European journal of cancer (Oxford, England : 1990) 1997;33(3):372-8.
1997: Goldschmidt H; Hegenbart U; Wallmeier M; Hohaus S; Engenhart R; Wannenmacher M; Haas R
High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(3):243-6.
1997: Dimitrakopoulou-Strauss A; Strauss L G; Goldschmidt H; Hegenbart U; Irngartinger G; Oberdorfer F; van Kaick G
[Positron emission tomography (PET) in diagnosis and therapy planning of malignant lymphoma]
Der Radiologe 1997;37(1):74-80.
1997: Goldschmidt H; Wallmeier M; Hegenbart U; Haas R
[Malignant lymphoma. Pathology, diagnosis, therapy]
Der Radiologe 1997;37(1):1-9.
1996: Haas R; Brittinger G; Meusers P; Murea S; Goldschmidt H; Wannenmacher M; Hunstein W
Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(12):1975-9.
1996: Voso M T; Murea S; Goldschmidt H; Hohaus S; Haas R
High-dose therapy with peripheral blood stem cell transplantation results in a significant reduction of the haemopoietic progenitor cell compartment.
British journal of haematology 1996;94(4):759-66.
1996: Goldschmidt H; Hegenbart U; Haas R; Hunstein W
Mobilization of peripheral blood progenitor cells with high-dose cyclophosphamide (4 or 7 g/m2) and granulocyte colony-stimulating factor in patients with multiple myeloma.
Bone marrow transplantation 1996;17(5):691-7.
1996: Haas R; Moos M; Möhle R; Döhner H; Witt B; Goldschmidt H; Murea S; Flentje M; Wannenmacher M; Hunstein W
High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Bone marrow transplantation 1996;17(2):149-55.
1996: Murea S; Goldschmidt H; Hahn U; Pförsich M; Moos M; Haas R
Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukaphereses.
Journal of clinical apheresis 1996;11(4):185-94.
1995: Goldschmidt H; Hahn U; Salwender H J; Haas R; Jansen B; Wolbring P; Rinck M; Hunstein W
Prevention of catheter-related infections by silver coated central venous catheters in oncological patients.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1995;283(2):215-23.
1995: Moos M; Schulz R; Cremer F; Sucker C; Schmohl D; Döhner H; Goldschmidt H; Haas R; Hunstein W
Detection of minimal residual disease by polymerase chain reaction in B cell malignancies.
Stem cells (Dayton, Ohio) 1995;13 Suppl 3():42-51.
1995: Goldschmidt H; Hegenbart U; Moos M; Eugenhart R; Wannenmacher M; Haas R; Hunstein W
Sequential high-dose treatment with peripheral blood progenitor cell transplantation in patients with multiple myeloma.
Stem cells (Dayton, Ohio) 1995;13 Suppl 3():36-41.
1995: Haas R; Murea S; Goldschmidt H; Döhner H; Moos M; Witt B; Eugenhart R; Wannenmacher M; Hunstein W
High-dose therapy with peripheral blood progenitor cell support in patients with non-Hodgkin's lymphoma.
Stem cells (Dayton, Ohio) 1995;13 Suppl 3():28-35.
1995: Hegenbart U; Goldschmidt H
[Gastrointestinal amyloidosis in IgG-kappa-light-chain plasmocytoma]
Deutsche medizinische Wochenschrift (1946) 1995;120(34-35):1187.
1995: Haas R; Witt B; Möhle R; Goldschmidt H; Hohaus S; Fruehauf S; Wannenmacher M; Hunstein W
Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support.
Blood 1995;85(12):3754-61.
1995: Dimitrakopoulou-Strauss A; Strauss L G; Goldschmidt H; Lorenz W J; Maier-Borst W; van Kaick G
Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas.
European journal of nuclear medicine 1995;22(5):434-42.
1995: Haas R; Moos M; Karcher A; Möhle R; Witt B; Goldschmidt H; Flentje M; Wannenmacher M; Hunstein W
[Sequential high-dose therapy in patients with low-malignity non-Hodgkin's lymphoma]
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1995;171(5):300-1.
1995: Haas R; Möhle R; Pförsich M; Fruehauf S; Witt B; Goldschmidt H; Hunstein W
Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells.
Blood 1995;85(7):1936-43.
1995: Hahn U; Goldschmidt H; Salwender H; Haas R; Hunstein W
Large-bore central venous catheters for the collection of peripheral blood stem cells.
Journal of clinical apheresis 1995;10(1):12-6.
1994: Haas R; Hohaus S; Goldschmidt H; Möhle R; Witt B; Wannenmacher M; Hunstein W
High-dose therapy and autografting with peripheral blood stem cells in malignant lymphoma: granulocyte-macrophage colony-stimulating factor for stem cell mobilization.
Seminars in oncology 1994;21(6 Suppl 16):19-24.
1994: Haas R; Moos M; Karcher A; Möhle R; Witt B; Goldschmidt H; Frühauf S; Flentje M; Wannenmacher M; Hunstein W
Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(8):1685-92.
1994: Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1994;170(7):383-90.
1994: Haas R; Möhle R; Frühauf S; Goldschmidt H; Witt B; Flentje M; Wannenmacher M; Hunstein W
Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma.
Blood 1994;83(12):3787-94.
1994: Haas R; Möhle R; Murea S; Goldschmidt H; Pförsich M; Witt B; Hunstein W
Characterization of peripheral blood progenitor cells mobilized by cytotoxic chemotherapy and recombinant human granulocyte colony-stimulating factor.
Journal of hematotherapy 1994;3(4):323-30.
1993: Haas R; Ehrhardt R; Witt B; Goldschmidt H; Hohaus S; Pförsich M; Ehrlich H; Färber L; Hunstein W
Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma.
Bone marrow transplantation 1993;12(6):643-9.
1993: Hohaus S; Goldschmidt H; Ehrhardt R; Haas R
Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
Experimental hematology 1993;21(4):508-14.
1993: Haas R; Hohaus S; Ehrhardt R; Goldschmidt H; Hunstein W
Autologous blood progenitor cell transplantation in relapsed Hodgkin's disease--the role of haematopoietic growth factors.
Bone marrow transplantation 1993;11 Suppl 2():30-5.
1993: Haas R; Hohaus S; Goldschmidt H; Witt B; Hunstein W
Hematopoietic growth factors for the mobilization of peripheral blood stem cells.
Journal of hematotherapy 1993;2(3):357-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hartmut Goldschmidt

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hartmut Goldschmidt (preview)

All Publications